SCTX Financials

Income Statement
MetricQ3 2026
Revenue
1.6M
Cost of Revenue
0
Gross Profit
1.6M
Operating Expenses
12.5M
R&D
8.3M
SG&A
4.2M
Operating Income
-10862000
EBITDA
-10244000
Net Income
-9863000
EPS (Basic)
$-0.68
EPS (Diluted)
$-0.68
Shares (Diluted)
14.5M
MarketsMoversWatchlist
Scribe Therapeutics (SCTX) — Financials